"10.1371_journal.pone.0127907","plos one","2015-05-21T00:00:00Z","S Anisah Alyahya; Scott T Nolan; Cara M R Smith; William R Bishai; Jerald Sadoff; Gyanu Lamichhane","Crucell Holland B.V., Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; HHMI, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","Conceived and designed the experiments: SAA GL JS. Performed the experiments: GL STN CMRS. Analyzed the data: SAA GL WRB JS. Contributed reagents/materials/analysis tools: SAA GL STN. Wrote the paper: SAA. Proofread and edited the manuscript: SAA GL WRB JS.","I have read the journal's policy and the authors of this manuscript have the following competing interests: The study was funded by an internal grant from Crucell Holland BV. JS and SAA are current and former employees of Crucell Holland BV, respectively. JS and SAA have been awarded a United States Patent (US 8,771,709 B2) on the use of Ad35-TBS and Ad26-TBS as therapeutic vaccines. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials.","2015","05","S Anisah Alyahya","SAA",6,TRUE,3,3,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
